论文部分内容阅读
Objective Significant heterogeneities in treatment outcomes were observed for stage Ⅱ nasopharyngeal carcinoma patients and the risk of distant metastasis(DM)was relatively high in some particular patients,searching robust predictive factors of high risk of DM for stage Ⅱ patients are urgently needed.